Rxsight Inc (RXST NASDAQ) stock market data APIs
$8.4696
-0.48(-5.7%)
as of July 10, 2025
Try our APIs with
free plan!
Rxsight Inc Financial Data Overview
Price chart is built with
Anychart
RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens (LAL), an intraocular lens made of photosensitive material that changes shape in response to specific patterns of ultraviolet, which can be adjusted to improve uncorrected visual acuity; and RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.
Prev. Close
8.4696
Open
7.9858
High
8.5517
Low
7.7072
52 wk Range
6.32-58.23
Market Cap
366 M
Shares Outstanding
40 637 K
Revenue
148 M
EPS
-0.03
Beta
1.288
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Rxsight Inc data using free add-ons & libraries
Get Rxsight Inc Fundamental Data
Rxsight Inc Fundamental data includes:
- Net Revenue: 148 M
- EBITDA: -33 626 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-06-06
- EPS/Forecast: -0.27
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Rxsight Inc News
New
Jefferies downgrades RxSight stock rating to Hold on elongated selling cycles
Investing.com - Jefferies downgraded RxSight Inc. (NASDAQ:RXST) from Buy to Hold on Thursday, while significantly reducing its price target to $9.00 from $24.00. The stock has already declined about 3...
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.49%
Investing.com – U.S. stocks were higher after the close on Wednesday, as gains in the Technology, Utilities and Industrials sectors led shares higher. At the close in NYSE, the Dow Jones Industrial...
Noteworthy Wednesday Option Activity: KSS, LUV, RXST
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Kohl's Corp. (Symbol: KSS), where a total of 44,987 contracts have traded so far, represent...
RxSight stock plunges after slashing 2025 revenue guidance
Investing.com -- RxSight (NASDAQ:RXST) stock plummeted 28% after the ophthalmic medical device company significantly lowered its 2025 revenue guidance following disappointing Light Delivery Device sal...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
